Combating Multidrug-Resistant Organisms: Strategic Considerations for Optimal Clinical Outcomes
 
Release Date: November 9, 2016
Last Reviewed: November 4, 2016
Expiration Date: November 9, 2017
Time to Complete Activity: 2.0 hours 
 
Faculty
Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP (Chair)
Chair, Division of Infectious Disease
Summa Health
Akron, OH
Professor, Internal Medicine
Master Teacher and Chair,
Infectious Disease Section
Northeast Ohio Medical University
Rootstown, OH
 
George H. Karam, MD
Paula Garvey Manship Chair of Medicine
Department of Medicine
Louisiana State University School of Medicine in New Orleans
Baton Rouge Branch Campus
Baton Rouge, LA
 
James S. Lewis II, PharmD, FIDSA
ID Clinical Pharmacy Supervisor
Oregon Health and Science University
Departments of Pharmacy & Infectious Diseases
Portland, OR
 
Hans H. Liu, MD, FACP
Director, Antimicrobial Stewardship
Bryn Mawr Hospital
Mainline Health System
Bryn Mawr, PA
Professor of Medicine
Sidney Kimmel School of Medicine
Thomas Jefferson University
Philadelphia, PA

This activity is provided by Paradigm Medical Communications, LLC.  
 
Target Audience
This activity has been designed to address the educational needs of infectious disease specialists and clinical pharmacists. This activity may also be of benefit to other healthcare professionals interested in the management of infections due to multidrug-resistant organisms.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Review pathogens responsible for most multidrug-resistant organism-related infections and their appropriate treatment.
  • Outline the appropriate integration of new and emerging antibiotics, alongside older, more established agents.
  • Summarize the tenets of effective antimicrobial stewardship, including the rationale, different interventions, and approaches to measuring process and outcomes.

Table of Contents
 
  1. Introduction
  1. Multidrug-Resistant Infections: Reviewing Common Pathogens and General Treatment Strategies
  1. New and Emerging Antibiotics: Data and Practical Recommendations
  1. Antimicrobial Stewardship: Effective Implementation for Improved Clinical Outcomes
  1. Case Studies with Audience Participation
 
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Pharmacist Accreditation and Designation Statement
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. (Universal Activity Number 0761-9999-16-282-H01-P)
 
This is a knowledge-based activity.
 
This activity is jointly provided by Educational Review Systems, Inc. and Paradigm Medical Communications, LLC.
                                                                                      
          
Disclosure of Commercial Support
This activity is supported by educational grants from Allergan, Inc; Cempra Pharmaceuticals, Inc; Tetraphase Pharmaceuticals, Inc; and The Medicines Company.
 
Instructions for Participation
To receive CME/CPE credit, you must:
  • Follow instructions to register or log in with your professional information and complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
 A certificate of participation/statement of completion will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 
Please note: to claim CPE credit, please make sure you include your date of birth and NABP number. All credit information will be uploaded into CPE Monitor within 30 days.
 
For questions regarding CME/CPE credit, contact the Paradigm CME Department at (845) 398-5949.

There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CME/CPE activity is designed using HTML5 audio.
 
Supported Browsers:
For desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues, please email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACCME and ACPE requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty
Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP (Chair)
Grant/Research Support: Nabriva Therapeutics AG; Pfizer Inc
Retained Consultant: Bayer HealthCare; Cempra Pharmaceuticals, Inc.; Melinta Therapeutics, Inc.; MotifBioSciences, Inc.; Nabriva Therapeutics AG; Paratek Pharmaceuticals Inc; Tetraphase Pharmaceuticals, Inc.
 
George H. Karam, MD
Retained Consultant: Philips Healthcare
Non-Speakers Bureau Activities: Merck & Co., Inc
 
James S. Lewis II, PharmD, FIDSA
Retained Consultant: Accelerate Diagnostics, Inc; Achaogen, Inc; Astellas Pharma US, Inc; The Medicines Company; Merck & Co., Inc; Paratek Pharmaceuticals, Inc
 
Hans H. Liu, MD, FACP
Retained Consultant: Cempra Pharmaceuticals, Inc.
Speakers Bureau: Daiichi Sanyko Co., Ltd,
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
 
Educational Review Systems, Inc. staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose. 
 
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC and Educational Review Systems, Inc. have implemented a system to resolve conflicts of interest for each CME/CPE activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME/CPE content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACPE Guidelines and ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME/CPE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or Educational Review Systems, Inc. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Paradigm Medical Communications, LLC and Educational Review Systems, Inc accept no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC and Educational Review Systems, Inc. are committed to protecting the privacy of those who participate in the activities (herein referred to as “website”) located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME/CPE activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC and Educational Review Systems, Inc. to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC and Educational Review Systems, Inc do not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC and Educational Review Systems, Inc. will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC and Educational Review Systems, Inc. staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2016 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.